Zur Kurzanzeige

dc.contributor.authorSchmidt, Annika
dc.contributor.authorFrei, Jana
dc.contributor.authorPoetsch, Ansgar
dc.contributor.authorChittka, Alexandra
dc.contributor.authorAßmann, Chris
dc.contributor.authorLehmkuhl, Anne
dc.contributor.authorBauer, Uta-Maria
dc.contributor.authorNuber, Ulrike
dc.contributor.authorCardoso, Cristina
dc.contributor.authorZhang, Hui
dc.date.accessioned2022-05-09T16:43:11Z
dc.date.available2022-05-09T16:43:11Z
dc.date.issued2022
dc.identifier.urihttps://tudatalib.ulb.tu-darmstadt.de/handle/tudatalib/3455
dc.identifier.urihttps://doi.org/10.48328/tudatalib-868
dc.descriptionRett syndrome is a human intellectual disability disorder that is associated with mutations in the X-linked MECP2 gene. The epigenetic reader MeCP2 binds to methylated cytosines on the DNA and regulates chromatin organization. We have shown previously that MECP2 Rett syndrome missense mutations are impaired in chromatin binding and heterochromatin reorganization. Here, we performed a proteomics analysis of post-translational modifications of MeCP2 isolated from adult mouse brain. We show that MeCP2 carries various post-translational modifications, among them phosphorylation on S80 and S421, which lead to minor changes in either heterochromatin binding kinetics or clustering. We found that MeCP2 is (di)methylated on several arginines and that this modification alters heterochromatin organization. Interestingly, we identified the Rett syndrome mutation site R106 as a dimethylation site. In addition, co-expression of protein arginine methyltransferases 1 and 6 lead to a decrease of heterochromatin clustering. Altogether, we identified and validated novel modifications of MeCP2 in the brain and show that these can modulate its ability to bind as well as reorganize heterochromatin, which may play a role in the pathology of Rett syndrome.de_DE
dc.language.isoende_DE
dc.rightsCreative Commons Attribution-NonCommercial 4.0
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.subjectArginine (di)methylationde_DE
dc.subjectHeterochromatin organizationde_DE
dc.subjectMeCP2de_DE
dc.subjectProtein arginine methyltransferasesde_DE
dc.subjectRett syndromede_DE
dc.subject.classification2.11-03 Zellbiologiede_DE
dc.subject.ddc570
dc.titleMeCP2 heterochromatin organization is modulated by arginine methylation and serine phosphorylationde_DE
dc.typeSoftwarede_DE
dc.typeImagede_DE
dc.description.versionPublic accessde_DE
tud.projectDFG | CA198/10-1 | Interaktion zwischende_DE
tud.projectDFG | CA198/16-1 | Rölle und Regulationde_DE
tud.projectDFG | NU119/3-1 | Interaktion zwischende_DE
tud.unitTUDa
tud.history.classificationVersion=2020-2024;201-03 Zellbiologie


Dateien zu dieser Ressource

Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail

Der Datensatz erscheint in:

Zur Kurzanzeige

Creative Commons Attribution-NonCommercial 4.0
Solange nicht anders angezeigt, wird die Lizenz wie folgt beschrieben: Creative Commons Attribution-NonCommercial 4.0